SIC
BIIB icon

Sigma Investment Counselors’s Biogen BIIB Stock Holding History

Sigma Investment Counselors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-800
Closed -$207K – 195
2023
Q4 		$207K Hold
800
– – 0.01% 188
2023
Q3 		$206K Hold
800
– – 0.02% 188
2023
Q2 		$228K Hold
800
– – 0.02% 178
2023
Q1 		$222K Buy
+800
New +$221K 0.02% 181
2022
Q1 		– Sell
-914
Closed -$219K – 192
2021
Q4 		$219K Sell
914
-42
-4% -$10.8K 0.02% 185
2021
Q3 		$271K Sell
956
-213
-18% -$69.8K 0.02% 161
2021
Q2 		$405K Buy
1,169
+109
+10% +$33K 0.03% 132
2021
Q1 		$297K Hold
1,060
– – 0.02% 150
2020
Q4 		$260K Buy
+1,060
New +$273K 0.02% 155
2020
Q2 		– Sell
-927
Closed -$293K – 156
2020
Q1 		$293K Hold
927
– – 0.04% 122
2019
Q4 		$275K Sell
927
-23
-2% -$6.38K 0.03% 129
2019
Q3 		$221K Sell
950
-73
-7% -$17K 0.03% 147
2019
Q2 		$239K Buy
1,023
+48
+5% +$11.1K 0.03% 144
2019
Q1 		$230K Sell
975
-45
-4% -$14.2K 0.03% 140
2018
Q4 		$307K Hold
1,020
– – 0.04% 116
2018
Q3 		$360K Buy
1,020
+25
+3% +$8.61K 0.04% 105
2018
Q2 		$289K Buy
+995
New +$280K 0.04% 106
2018
Q1 		– Sell
-636
Closed -$203K – 128
2017
Q4 		$203K Buy
+636
New +$204K 0.03% 125

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sigma Investment Counselors's BIIB Position: Q1 2024 in Review

Sigma Investment Counselors sold out of Biogen (BIIB) in Q1 2024, closing a stake of 800 shares — an estimated $207K sold.

Sigma Investment Counselors first reported a position in BIIB in Q4 2017 and held it in 18 quarters. The position peaked at $405K in Q2 2021. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Sigma Investment Counselors reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Sigma Investment Counselors sold 800 Biogen shares in Q1 2024, an estimated $207K.
  • Sigma Investment Counselors first reported a position in Biogen in Q4 2017 and held it in 18 quarters.
  • Sigma Investment Counselors's Biogen position peaked at $405K in Q2 2021.
  • 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Sigma Investment Counselors's 13F filing for Q1 2024, filed 25 Apr 2024.